Advertisement
William C. Weldon, chairman and chief executive officer of Johnson &Johnson, chairs the CEO Roundtable on Cancer, the nonprofit organization ofcancer-fighting CEOs that created the CEO Cancer Gold Standard(TM), incollaboration with leading health professionals. "Adopting the Gold Standardis a tribute to the value these CEOs place on their employees and to theextraordinary leadership they provide their organizations and to all of thosecommitted to winning the battle against cancer."
Advertisement
The CEO Cancer Gold Standard(TM), calls for companies to evaluate theirbenefits and culture and take extensive, concrete actions in five key areas ofhealth and wellness to fight cancer in the workplace. To earn Gold Standardaccreditation, a company must establish programs to reduce cancer risk bydiscouraging tobacco use and encouraging physical activity, healthy diet andnutrition; detect cancer at its earliest stages; and provide access to qualitycare, including the availability of clinical trials.
Earlier this year, the President's Cancer Panel report, "Promoting HealthyLifestyles: Policy, Program, and Personal Recommendations for Reducing CancerRisk," identified the CEO Cancer Gold Standard(TM) as an initiative that ishelping reverse negative, unhealthy lifestyle trends and creating hope in thefight against cancer for America's workers and their families.
In addition to Duke Medicine, The University of North Dakota and ValeantPharmaceuticals, thirteen other companies have received the CEO Cancer GoldStandard(TM) accreditation from the CEO Roundtable on Cancer. They are:American Cancer Society (national headquarters), American Legacy Foundation,AstraZeneca, Edelman, Enzon Pharmaceuticals, GlaxoSmithKline, Jenner & Block,Johnson & Johnson, MD Anderson Cancer Center, Novartis, OSI Pharmaceuticals,Quintiles Transnational and SAS Institute.
About the CEO Roundtable on Cancer
The CEO Roundtable on Cancer was founded in 2001, when former PresidentGeorge H.W. Bush challenged a group of executives, led by Robert A. Ingram,then the CEO of Glaxo Wellcome, now GlaxoSmithKline, to "do something bold andventuresome about cancer within your own corporate families." The CEOsresponded with the CEO Cancer Gold Standard, and have since collaborated withthe American Cancer Society to encourage its widespread adoption in workplacesacross the country. For more information on the CEO Cancer Gold Standard(TM)and the accreditation process, please call 866-526-7830 or visithttp://www.CancerGoldStandard.org.
To read the President's Cancer Panel report, please go to:http://deainfo.nci.nih.gov/advisory/pcp/pcp07rpt/pcp07rpt.pdf
This release was issued through eReleases(TM). For more information,visit http://www.ereleases.com.For more information: CEO Roundtable on Cancer John Dornan, Executive Director P: 919-531-0966 E: [email protected]
SOURCE CEO Roundtable on Cancer
